ARYZTA (ARYN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
2 Mar, 2026Executive summary
Revenue reached €2,223.3m for FY2025, with organic growth of 1.5% driven by both volume and price increases.
EBITDA was €306.9m with a margin of 13.8%, reflecting resilience amid cost inflation and subdued consumer spending.
Free cash flow totaled €120.0m, supporting a 5.7% increase in EPS to €4.25.
Leadership transition completed, with Urs Jordi as permanent CEO and a new independent Chair proposed for 2027; head office relocation to Zug pending AGM approval.
Strategic repositioning included key customer negotiations, innovation driving 19% of revenue, and new capacity investments in Switzerland, Portugal, and Poland.
Financial highlights
Revenue increased to €2,223.3m from €2,194.5m year-over-year; organic growth was 1.5%.
EBITDA margin at 13.8% (down from 14.6% in 2024) due to input cost inflation, partially offset by pricing and cost savings.
Free cash flow was €120.0m, with disciplined CAPEX and improved working capital efficiency.
EPS increased 5.7% to €4.25, driven by operating performance and lower financing costs.
Net debt reduced to €645.9m, with leverage ratio improving to 2.6x.
Outlook and guidance
Midterm plan targets confirmed: low-to-mid single-digit organic growth, EBITDA margin ≥15%, EBIT margin ≥9%.
CapEx to remain at 3.5%-4.5% of revenue; net debt leverage targeted at 1.5-2x.
Guidance for 2026 expects continued strong free cash flow, further EBITDA and EBIT improvement, and stable financing costs.
Board to publish a capital return policy in 2026, with potential for dividends or share buybacks.
Plans to repurchase last remaining hybrid bond (CHF 144.3m) at next interest payment date.
Latest events from ARYZTA
- EBITDA margin rose to 14.2% on €1,055.2m revenue, with leverage down to 2.9x.ARYN
H1 20241 Feb 2026 - FY2025 targets exceeded, with strong EBITDA, cash flow, and major investment in Portugal.ARYN
Q4 2025 TU22 Jan 2026 - EBITDA guidance reset to €300m for 2025; interim CEO appointed to drive improvements.ARYN
Investor Update14 Dec 2025 - Midterm targets met early, with higher margins, strong cash flow, and double-digit EPS growth.ARYN
H2 202410 Dec 2025 - Revenue and EPS rose, with margin pressured by inflation but guidance reaffirmed.ARYN
H1 202523 Nov 2025 - Targets above-market growth and >15% EBITDA margin by 2028 through innovation and efficiency.ARYN
CMD 202517 Nov 2025 - Q3 organic growth 0.8%, YTD 2.1%, FY25: €300m EBITDA, €100m free cash flow, cost optimisation.ARYN
Q3 2025 TU20 Oct 2025 - Innovation-led growth, margin expansion, and strong cash flow drive ARYZTA's robust performance.ARYN
Investor Presentation13 Jun 2025 - Q3 organic growth rebounded to 2.0%, with strong volumes and cost-saving initiatives underway.ARYN
Q3 2024 TU13 Jun 2025